Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multi-site, cross sectional feasibility pilot study
2019
Reducing AF-related stroke risk is both
clinically and economically important, with AF-related
illness costing the NHS over £2 billion per annum. Despite
this, there is no national screening programme for AF.
Growing medical consensus backed by public health
policy, agrees that there is an unmet need to improve
diagnosis and that primary care is an appropriate setting.
This model is likely to be convenient for patients and cost
effective, but with the current shortage of GPs and nurses,
and increasing GP workloads, it is unlikely to succeed.
Huge investment by NHS England to introduce new work
role models to GP practices, could mean, by 2021, that
over 34 million patients will have access to the expertise
of a clinical pharmacist, making clinical pharmacists a
viable option for such screening initiatives.
AIM: To determine whether clinical pharmacists based
within GP practices, were able to accurately and effectively
screen and diagnose patients for AF, using pulse
palpation and a single-lead ECG device (AliveCor Kardia
Mobile®) during the infl uenza vaccination season.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI